Search Results - "Guillemaut, S."

Immune cell dysfunctions in breast cancer patients detected through whole blood multi-parametric flow cytometry assay by Verronèse, E., Delgado, A., Valladeau-Guilemond, J., Garin, G., Guillemaut, S., Tredan, O., Ray-Coquard, I., Bachelot, T., N'Kodia, A., Bardin-Dit-Courageot, C., Rigal, C., Pérol, D., Caux, C., Ménétrier-Caux, C.

“…Monitoring functional competence of immune cell populations in clinical routine represents a major challenge. We developed a whole-blood assay to monitor…”
Get full text

Sequential high-dose chemotherapy protocol for relapsed poor prognosis germ cell tumors combining two mobilization and cytoreductive treatments followed by three high-dose chemotherapy regimens supported by autologous stem cell transplantation. Results of the phase II multicentric TAXIF trial by Lotz, J.-P., Bui, B., Gomez, F., Théodore, C., Caty, A., Fizazi, K., Gravis, G., Delva, R., Peny, J., Viens, P., Duclos, B., De Revel, T., Curé, H., Gligorov, J., Guillemaut, S., Ségura, C., Provent, S., Droz, J.-P., Culine, S., Biron, P.

“…Background: High-dose chemotherapy (HD-CT) is able to circumvent platinum resistance of resistant/refractory germ-cell tumors (GCTs), but expectancy of cure…”
Get full text

Design of a randomised controlled trial of adapted physical activity during adjuvant treatment for localised breast cancer: the PASAPAS feasibility study by Touillaud, M, Foucaut, A-M, Berthouze, S E, Reynes, E, Kempf-Lépine, A-S, Carretier, J, Pérol, D, Guillemaut, S, Chabaud, S, Bourne-Branchu, V, Perrier, L, Trédan, O, Fervers, B, Bachmann, P

“…Introduction After a diagnosis of localised breast cancer, overweight, obesity and weight gain are negatively associated with prognosis. In contrast,…”
Get full text

ISO 9001 certification of innovation and clinical research departments: Extending the scope of health assessment by Sambou, C, Guillemaut, S, Morelle, M, Achache, A, Le Corroller, A-G, Perol, D, Perrier, L

“…The International organization for standardization (ISO) is the world leader in providing industrial and commercial standards and certifications. Beyond…”
Get more information

PCN89 - A Cost-Effectiveness Analysis of a 6-Month Physical Activity Program Versus Usual Dietary Care During Adjuvant Chemotherapy in Breast Cancer Patients by Perrier, L, Foucaut, A, Touillaud, M, Kempf-Lepine, AS, Morelle, M, Heinz, D, Gomez, F, Meyrand, R, Baudinet, C, Berthouze, S, Carretier, J, Denizot-Guillemaut, S, Pérol, D, Trédan, O, Philip, T, Reynes, E, Bachmann, P, Fervers, B

Get full text

A Cost-Effectiveness Analysis of a 6-Month Physical Activity Program Versus Usual Dietary Care During Adjuvant Chemotherapy in Breast Cancer Patients by Perrier, L, Foucaut, A, Touillaud, M, Kempf-Lepine, AS, Morelle, M, Heinz, D, Gomez, F, Meyrand, R, Baudinet, C, Berthouze, S, Carretier, J, Denizot-Guillemaut, S, Pérol, D, Trédan, O, Philip, T, Reynes, E, Bachmann, P, Fervers, B

Get full text